Full Name
Linda Katz
Job Title
Director, Office of Cosmetics and Colors
Company
FDA
Speaker Bio
Dr. Linda Katz has held a variety of positions at the FDA. Since 2002 she has been the Director for the Office of Cosmetics and Colors (OCAC), has served as Chief Medical Officer in FDA’s Center for Food Safety and Applied Nutrition (CFSAN) since 2007, and was the Acting Deputy Director for Operations at CFSAN from September 2012 through March 2013. As Director of OCAC, she establishes the priorities and missions of OCAC, focusing on cosmetic safety, compliance, certification of color additives research, such as nanotechnology, phototoxicity and percutaneous absorption. As Chief Medical Officer she addresses safety and medical concerns for CFSAN regulated products. She has received numerous awards. She has also presented on a wide variety of topics in both the U.S and abroad, and has had numerous publications in relevant regulatory areas, including those related to cosmetics, nanotechnology from a cosmetic and food perspective, and drug related issues.
Prior to assuming leadership of OCAC, she began her FDA career in the Center for Drug Evaluation and Research (CDER), in 1989, holding positions of Deputy Director for the Division of Over-the-Counter Drug Products, Deputy Director for the Division of Dermatologic and Dental Drug Products, and Team Leader and Acting Director for the Pilot Drug Evaluation Staff. Dr. Katz received her B.A., magna cum laude, in biology from the University of Pennsylvania, a M.P.H. in epidemiology and health planning from the University of Michigan, and her M.D. from the University of Connecticut. She completed her internship and residency in Internal Medicine, and fellowship in Rheumatology, at the George Washington University Medical Center, in Washington, D.C.
She is a Fellow in the American College of Physicians, a Fellow Member of the American College of Rheumatology, and is boarded in Internal Medicine with a subspecialty in Rheumatology. In addition, Dr. Katz maintains an academic appointment, as Associate Clinical Professor of Medicine, at The Uniformed Services University of the Health Sciences. In her latter position she continues to teach.
Prior to assuming leadership of OCAC, she began her FDA career in the Center for Drug Evaluation and Research (CDER), in 1989, holding positions of Deputy Director for the Division of Over-the-Counter Drug Products, Deputy Director for the Division of Dermatologic and Dental Drug Products, and Team Leader and Acting Director for the Pilot Drug Evaluation Staff. Dr. Katz received her B.A., magna cum laude, in biology from the University of Pennsylvania, a M.P.H. in epidemiology and health planning from the University of Michigan, and her M.D. from the University of Connecticut. She completed her internship and residency in Internal Medicine, and fellowship in Rheumatology, at the George Washington University Medical Center, in Washington, D.C.
She is a Fellow in the American College of Physicians, a Fellow Member of the American College of Rheumatology, and is boarded in Internal Medicine with a subspecialty in Rheumatology. In addition, Dr. Katz maintains an academic appointment, as Associate Clinical Professor of Medicine, at The Uniformed Services University of the Health Sciences. In her latter position she continues to teach.
Speaking At
